Clinical trial
Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid…
NCT00262327 · Sun Yat-sen University, Other · Unknown status
Key facts
| NCT number | NCT00262327 |
|---|---|
| Title | Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor |
| Official title | Phase I Trial of Intratumoral Injection of an Adenovirus Encoding Human Endostatin for Advanced Solid Tumors |
| Lead sponsor | Sun Yat-sen University, Other |
| Collaborators | Doublle Bioproduct Inc Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Solid Tumor |
| Intervention type | Drug, Genetic |
| Interventions | Antangiogenesis, endostatin gene |
| Enrollment | 20 |
| Start date | May 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Dec 6, 2005 |
| Last update posted | Jun 20, 2006 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: